Related Experiment Video
Updated: Jun 30, 2025

Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
Coenzyme Q10 in atherosclerosis
Minjun Liao1, Xueke He2, Yangyang Zhou1
1Institute of Cardiovascular Disease, Department of Pathophysiology, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical College, University of South China, Hengyang, 421001, PR China; Department of Clinical Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, PR China.
Insights
Coenzyme Q10 (CoQ10) demonstrates protective effects against atherosclerosis, a major cause of cardiovascular death. Research indicates CoQ10 may mitigate key disease processes, suggesting its therapeutic potential.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Nutritional Science
Background:
- Atherosclerosis is a leading cause of global cardiovascular mortality, particularly in the elderly.
- Key pathological processes include abnormal lipid metabolism, endothelial dysfunction, inflammation, and oxidative stress.
- Coenzyme Q10 (CoQ10) is an essential mitochondrial component and potent antioxidant.
Purpose of the Study:
- To review the role of CoQ10 in the electron transport chain and its antioxidant functions.
- To explore CoQ10's physiological impact on oxidative stress, inflammation, lipid metabolism, and autophagy.
- To assess CoQ10's therapeutic potential in mitigating atherosclerosis progression.
Main Methods:
- Literature review of CoQ10's forms in the electron transport chain.
- Analysis of CoQ10's physiological regulatory roles.
- Examination of molecular mechanisms, animal models, and clinical evidence of CoQ10 in atherosclerosis.
Main Results:
- CoQ10 mitigates lipid transport abnormalities, endothelial inflammation, metabolic disturbances, and thrombotic processes in atherosclerosis.
- Evidence from molecular, animal, and clinical studies supports CoQ10's beneficial effects.
- Combined CoQ10 therapy shows synergistic effects with other drugs.
Conclusions:
- CoQ10 exhibits significant potential as a therapeutic agent for atherosclerotic cardiovascular diseases.
- Further basic and clinical research is warranted to fully establish CoQ10's role in treatment.
- CoQ10 may offer a novel strategy to combat cardiovascular mortality associated with atherosclerosis.
Abstract:
Atherosclerotic disease is a chronic disease that predominantly affects the elderly and is the most common cause of cardiovascular death worldwide. Atherosclerosis is closely related to processes such as abnormal lipid transport and metabolism, impaired endothelial function, inflammation, and oxidative stress. Coenzyme Q10 (CoQ10) is a key component of complex Ⅰ in the electron transport chain and an important endogenous antioxidant that may play a role in decelerating the progression of atherosclerosis. Here, the different forms of CoQ10 presence in the electron transport chain are reviewed, as well as its physiological role in regulating processes such as oxidative stress, inflammatory response, lipid metabolism and cellular autophagy. It was also found that CoQ10 plays beneficial effects in atherosclerosis by mitigating lipid transportation, endothelial inflammation, metabolic abnormalities, and thrombotic processes from the perspectives of molecular mechanisms, animal experiments, and clinical evidence. Besides, the combined use of CoQ10 with other drugs has better synergistic therapeutic effects. It seems reasonable to suggest that CoQ10 could be used in the treatment of atherosclerotic cardiovascular diseases while more basic and clinical studies are needed.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Role of Reduced Coenzymes NADH and FADH₂
Cholesterol: Significance and Regulation
Considering cholesterol and...
Electron Transport Chain: Complex III and IV
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cofactors and Coenzymes

